We have developed a cartridge-type receiver covering the frequency band of 385-500 GHz as a qualification model of Atacama Large Millimeter/submillimeter Array (ALMA) band 8. It receives two orthogonal polarizations and down-converts the sideband-separated signals to intermediate frequencies (IF) of between 4 and 8 GHz. The cartridge-type receiver consists of cold optics, two feed horns, a wire grid, mirrors, two sideband-separating SIS mixers, cryogenic multipliers of a local oscillator (LO), cryogenic and warm IF amplifiers, a cartridge body, and sensors/wirings. These components were individually tested, and then the cartridge was integrated and tested as a complete assembly. We have also developed equipment for efficiency tests of both the components and the integrated receiver. The single sideband (SSB) noise temperature of this receiver is 100 K at the band center and 300 K at the band edges. The beam pattern and cross-polarization pattern are consistent with a physical optical calculation. The amplitude stability is around $3 \times 10^{-4}$ in 1 s. The phase stability is less than 2.0D on a time scale of 0.1 s to 10 min. These results are promising for a receiver in the ALMA.
We present design and evaluations of a submillimeter double-ridged waveguide ortho-mode transducer (OMT) for ALMA Band 8 (385-500 GHz) cartridge receiver. The measured transmission loss of the OMT at 4 K was 0.4-0.5 dB according to noise measurements with an SIS mixer. The polarization isolation was measured to be larger than 29 dB from quasioptical measurements. The OMT consists of a Bfifot junction and a double-ridged guide. A robust design with allowable mechanical errors of 20 μm has been demonstrated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.